Pathophysiology, diagnosis and management of cardiac toxicity induced by immune checkpoint inhibitors and BRAF and MEK inhibitors
Dimitri Arangalage, Nils Degrauwe, Olivier Michielin, Pierre Monney, Berna C. Özdemir
Topics & Concepts
MedicineCardiotoxicityMyocarditisMelanomaDiscontinuationAdverse effectSorafenibInternal medicineOncologyPharmacologyChemotherapyCancer researchHepatocellular carcinomaMelanoma and MAPK PathwaysCAR-T cell therapy researchCancer Immunotherapy and Biomarkers